-
March 31, 2021 Interview With Nick LevichPsychedelic Passage’s Co-Founder and Facilitator, Nick Levich, talks about the function, purpose and importance of...
-
March 31, 2021 Interview With Pierre BouchardPsychotherapist, Pierre Bouchard talks with our Director of Content, Jill Ettinger.
-
March 30, 2021 Andrew Yang Supports LEGALIZING PSILOCYBIN in New York (But Can He Do It?)Hello psychedelic investors! Today's episode is a bit different yet still relevant to all of...
-
March 29, 2021 Fireside ProjectFireside Project is excited to launch on April 14th as a 24/7 support hotline
-
March 29, 2021 HUGE News on Compass Pathways (CMPS) Patents [ + Updates on MINDMED (MMED/MMEDF) ENBI, CYBN & MYCOF]In today's episode of "This Week in Psychedelic Stocks", we have News on MindMed (MMED...
-
March 26, 2021 Cathie Wood of Ark Invest Comments on Psychedelic Stocks like MindMed “We DON’T Invest In Binaries”Will Ark Invest (ARKK) and Cathie Wood invest in MindMed ( MMED / MMEDF/ MMQ)...
-
March 23, 2021 Interview With Dr. Steven MandelIn this episode of the Psychedelic Spotlight podcast, we have the distinct privilege of speaking...
-
March 23, 2021 Interview With Sacha HebbertMind Cure Health's Senior Product and Marketing Manager, Sacha Hebbert, talks about the company's recent...
-
March 22, 2021 UFC Explores Psychedelic Therapy for Brain-Injured FightersThe UFC (Ultimate Fighting Championship) is working with industry leaders to better understand brain trauma-related...
-
March 22, 2021 This Week in Psychedelic Stocks [UPDATES ON MINDMED (MMED/MMEDF) CMPS, NUMI, FTPRF, ATAI & CYBN]In today's episode of "This Week in Psychedelic Stocks", we'll see some News on MindMed...